CDIB Capital
Tier 3 Industrial
Bio
CDIB Capital CDIB Capital is Taiwan's leading PE/VC firm, founded in 1959 with 80+ NTD billion in AUM (roughly $2.5B). Over 60+ years, the firm has invested in 250+ companies with 100+ investment professionals. The portfolio of 109 companies is weighted toward life sciences (29 companies) and high tech (15). Investment sectors include semiconductors, electronics, biomedical, automotive, and internet. The Greater China focus extends through the NexGen Partners buyout platform for mid-market deals
Industries
SemiconductorsBiotechMedTechAdvanced Manufacturing
Stages
SeedSeries A
Geography
ChinaSoutheast Asia
Notable investments
- TXOne
- Anbogen Therapeutics